A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Brainsway Ltd. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 45,700 shares of BWAY stock, worth $419,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,700
Previous 19,200 138.02%
Holding current value
$419,526
Previous $116,000 263.79%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.8 - $9.24 $153,700 - $244,860
26,500 Added 138.02%
45,700 $422,000
Q2 2024

Aug 14, 2024

BUY
$4.75 - $7.08 $91,200 - $135,936
19,200 New
19,200 $116,000

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $152M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.